World's Best Scientists 2026 revealed!
Tsuneyo Mimori

Tsuneyo Mimori

D-Index & Metrics

Immunology

D-Index
91
Citations
33715
World Ranking
1029
National Ranking
36

Medicine

D-Index
91
Citations
33738
World Ranking
11673
National Ranking
344

Tsuneyo Mimori publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tsuneyo Mimori sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 607 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tsuneyo Mimori D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tsuneyo Mimori sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 91 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tsuneyo Mimori is affiliated with Kyoto University in Japan and has contributed extensively to the field of medicine, with a focus on rheumatology, immunology, epidemiology, pathology and forensic medicine, and genetics. Their research spans various subfields and topics related primarily to autoimmune and inflammatory diseases.

The scientist's work addresses several key topics including:

  • Inflammatory Myopathies and Dermatomyositis
  • Rheumatoid Arthritis Research and Therapies
  • Immunodeficiency and Autoimmune Disorders
  • Systemic Lupus Erythematosus Research
  • Monoclonal and Polyclonal Antibodies Research
  • Eosinophilic Disorders and Syndromes
  • T-cell and B-cell Immunology

Mimori has published articles in numerous venues, with frequent contributions to:

  • Modern Rheumatology
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • Frontiers in Immunology
  • Arthritis Research & Therapy

Some of their recent notable publications include:

  • "Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases," 2021, Cell
  • "Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis," 2022, Nature Genetics
  • "Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment," 2020, Lara D. Veeken
  • "The International Consensus on ANA Patterns (ICAP) in 2021-The 6th Workshop and Current Perspectives," 2021, The Journal of Applied Laboratory Medicine
  • "How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative," 2021, Immunologic Research

Frequent co-authors collaborating with Mimori include:

  • Hajime Yoshifuji
  • Koichiro Ohmura
  • Ran Nakashima
  • Akio Morinobu
  • Motomu Hashimoto

The combination of clinical insights and genetic analysis is a consistent theme in Mimori's work, particularly in the context of immune-mediated diseases and autoimmune conditions. Their multidisciplinary approach incorporates investigations into molecular mechanisms, disease phenotypes, and clinical therapies, emphasizing thorough characterization of inflammatory and autoimmune disorders.

Best Publications

  • Genetics of rheumatoid arthritis contributes to biology and drug discovery

    Yukinori Okada;Yukinori Okada;Di Wu;Di Wu;Di Wu;Gosia Trynka;Gosia Trynka;Towfique Raj;Towfique Raj

  • Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease

    A. Khosroshahi;Z. S. Wallace;J. L. Crowe;T. Akamizu

  • A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

    Shinji Sato;Michito Hirakata;Masataka Kuwana;Akira Suwa

  • Mechanism of interaction between Ku protein and DNA.

    T Mimori;J A Hardin

  • Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.

    T Mimori;M Akizuki;H Yamagata;S Inada

  • The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies.

    I Pettersson;M Hinterberger;T Mimori;E Gottlieb

  • Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders.

    T Mimori;J A Hardin;J A Steitz

  • Efficacy of rituximab (Anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

    Mikiko Tokunaga;Kazuyoshi Saito;Daisuke Kawabata;Yoshitaka Imura

  • The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

    Ran Nakashima;Yoshitaka Imura;Shio Kobayashi;Naoichiro Yukawa

  • Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population

    Yukinori Okada;Chikashi Terao;Katsunori Ikari;Yuta Kochi

  • Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014–2015

    Edward K. L. Chan;Jan Damoiseaux;Orlando Gabriel Carballo;Karsten Conrad

  • Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

    Unknown

  • Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome

    Kazuhiko Arima;Akira Kinoshita;Hiroyuki Mishima;Nobuo Kanazawa

  • A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.

    Yuta Kochi;Yukinori Okada;Akari Suzuki;Katsunori Ikari

  • Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

    Y Tanaka;T Takeuchi;T Mimori;K Saito

  • Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis

    Kei Hoshino;Yoshinao Muro;Kazumitsu Sugiura;Yasushi Tomita

  • Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective

    Jan Damoiseaux;Luis Eduardo Coelho Andrade;Orlando Gabriel Carballo;Karsten Conrad

  • Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis

    Hideaki Tsuji;Ran Nakashima;Yuji Hosono;Yoshitaka Imura

  • The Precipitating Antibody to an Acidic Nuclear Protein Antigen, the Jo-1, in Connective Tissue Diseases

    Shunji Yoshida;Masashi Akizuki;Tsuneyo Mimori;Hajime Yamagat

  • Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.

    Hajime Yoshifuji;Takao Fujii;Shio Kobayashi;Yoshitaka Imura

Frequent Co-Authors

Fumihiko Matsuda
Fumihiko Matsuda Kyoto University
Hisashi Yamanaka
Hisashi Yamanaka International University of Health and Welfare
Yoshiya Tanaka
Yoshiya Tanaka University of Occupational and Environmental Health Japan
Masataka Kuwana
Masataka Kuwana Nippon Medical School
Takayuki Sumida
Takayuki Sumida University of Tsukuba
Ryo Yamada
Ryo Yamada Kyoto University
Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Yukinori Okada
Yukinori Okada Osaka University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals consider advancing their expertise through specialized nursing paths, such as becoming an Acute Care Nurse Practitioner. Earning an acute care nurse practitioner certification allows nurses to provide critical care to patients with complex conditions, a skill highly valuable in immunology-related fields.

Transitioning from a Registered Nurse (RN) to a Nurse Practitioner (NP) can be streamlined through various accelerated RN to NP programs. These programs offer efficient pathways to expand clinical and diagnostic abilities, complementing the study of immunological disorders and patient care.

For individuals without a nursing background, there are accessible routes to enter the healthcare field, such as online ADN programs for non nurses. These programs provide foundational nursing education, which can be a stepping stone toward specialized immunology or advanced practice roles.

Understanding compensation trends is also crucial when planning a career. Those pursuing advanced practice degrees like the Doctor of Nursing Practice (DNP) should explore the highest paid DNP specialties to align their interests with rewarding career paths. This insight helps in making informed decisions about education and specialization in immunology-related healthcare fields.

Best Scientists Citing Tsuneyo Mimori

Trending Scientists

Recently Published Articles